Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06665451

Erythropoietin Gel Effect on Dental Implant Stability

Evaluation of Erythropoietin Gel Effect on Stability of Immediate Implant ( Clinical and Radiographical Study )

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

* Achieving and maintaining long-term osseointegration for dental implants is a key objective in the field of dentistry. The success of osseointegration is influenced by the surface treatment applied to dental implants. Numerous coating techniques have been developed to improve and speed up osseointegration. * The aim of the current study is to assess immediate dental implant stability coated with erythropoietin gel, both clinically and radiographically. * Materials and Methods: We conducted a randomized controlled clinical trial.The sample will include patients demanding immediate implant treatment in the anterior maxilla . Patients will be randomly allocated into the two groups of the study. The group A will be treated with erythropoietin gel coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . Group B will be treated with non coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . * The primary outcome variable will be implant stability and the secondary outcome will be crestal marginal bone level and bone density around implants. It will be measured at time of implant placement and reevaluated after 6-months .

Conditions

Interventions

TypeNameDescription
OTHERNon coated dental implantsPatients with fresh extraction sockets in the anterior maxilla will be treated by non coated immediate implant .
OTHERErythropoietin gel coated implantsPatients with fresh extraction sockets in the anterior maxilla will be treated by immediate implant coated by erythropoietin gel.

Timeline

Start date
2024-11-01
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2024-10-30
Last updated
2024-10-30

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06665451. Inclusion in this directory is not an endorsement.